INS and type 1 diabetes mellitus: The recent SWITCH (Sensing with Insulin pump Therapy to Control HbA1c) study investigated the impact on metabolic control of combining CGM with CSII therapy in a mixed population of paediatric and adult patients with type 1 diabetes [11].